In what is believed to be the largest epigenetic analysis to date of cell-signaling molecules in early-stage melanoma, researchers at NYU Langone Medical Center have identified two tiny bits of non-coding genetic material in primary tumours that appear critical to stalling the cancer’s spread, and essentially setting the biological fate of the disease. Reporting in the Journal of the National Cancer Institute, researchers say that … Continue reading Largest ever analysis maps epigenetic methylation pathway which suppresses the spread of melanoma.